Intergroupe Francophone Du Myelome

This large, late-stage trial is testing whether a new drug combination can work as well as or better than the current standard treatment for newly diagnosed multiple myeloma. The study will compare a regimen that includes the drugs elranatamab and lenalidomide against the usual a…